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Objectives
At the conclusion of this session, the participant will 
be able to:
 Outline key talking points to communicate to a patient 
who has been prescribed opioid therapy.
 Provide practical strategies to help motivate a patient’s 
commitment to opioid therapy adjustment.
 Apply a patient-centered, six-step process to minimize 
conflict when communicating opioid dosing 
recommendations.
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Effective communication is critical when
• Communicating important information
 (For example, “Taking opioids with alcohol or other drugs can cause you 
to stop breathing and die.”)
• Motivating behavior change 
 (For example, committing to taper opioids)
• Addressing conflicts 
(For example, “I don’t think opioids will help your headaches.”)
Discuss benefits and risks
with patients
• Before starting and periodically during opioid therapy, clinicians should discuss 
with patients known risks and realistic benefits of opioid therapy and patient 
and clinician responsibilities for managing therapy.
(Recommendation category A: Evidence type: 3)
Important points for patients about opioids
• We don’t know how well opioids work long-term
• They probably won’t take away your pain completely
• Opioids can cause you to stop breathing and die, especially 
at high doses, or if taken with alcohol or other drugs
• You could develop a serious, lifelong addiction
• They can cause constipation, dry mouth, nausea, vomiting, 
withdrawal, drowsiness, and might make driving unsafe 
• We’ll meet often to make sure they are not harming you
• I test urine and check a database showing medicines from 
other doctors to be sure all my patients on opioids are safe 
Communicating important information
• Pause and ask the patient what they heard you say
• Correct misunderstandings
• Ask if there are questions
• Allow adequate time
Two principles for effective communication
• Approach patients with compassion
• Use relationship-building skills, including
– reflective listening 
– empathic statements
What about patients already taking high opioid dosages?
• Explain there is now scientific evidence showing overdose 
risk increases at higher opioid doses 
• Empathically review benefits and risks of continued high-
dose opioid therapy 
• Offer to work with the patient to taper to a safer dose
• Motivational interviewing can move the patient toward 
readiness for change
Principles of motivational interviewing
• Express empathy through reflective listening
• Develop discrepancy between clients' goals or values and their current 
behavior
• Avoid argument and direct confrontation
• Adjust to client resistance rather than opposing it directly
• Support self-efficacy and optimism
Miller, W.R., and Rollnick, S. Motivational Interviewing: Preparing 
People To Change Addictive Behavior. New York: Guilford Press, 1991
Express empathy through reflective listening
• Ask open-ended questions
For example, “What concerns do you have about opioids?”
• Listen
• Reflect
• Express appropriate empathy
For example, “The idea of changing your opioid dose after all these years 
must be frightening.”
Develop discrepancy between clients' goals or values and their 
current behavior
• Reflect back content from the patient 
• Elicit ambivalent statements with nonjudgmental, reflective listening
• Ask about goals and how opioids help or don’t help
• Reflect ambivalence back to the patient
For example, “You said that opioids used to control the pain, but they 
aren’t working very well anymore. What makes you want to continue 
taking them the same way?”
Avoid argument and direct confrontation
• Argument and direct confrontation can reinforce a defensive, oppositional 
stance 
• Recognize patient resistance as a signal
– listen more carefully 
– change direction
Adjust to client resistance rather than opposing it directly
• Adjust to resistance rather than opposing it directly (also called “rolling with 
resistance”) 
• Reflect what the patient just said in a neutral way 
For example, “You aren’t ready to think about planning to reduce your 
dose yet.”
• Reframe the conversation
For example, “I care about you and want to help you get back to being as 
active as you would like.”
Support self-efficacy and optimism
• Reinforce signals that the patient is considering change
For example, “I think it’s great that you want to hear more about other 
ways to manage your pain.” 
• Provide credible, clear, actionable information 
For example, “Most people can function better without worse pain after 
tapering opioids. Many patients have improved pain after a taper, even 
though pain might briefly get worse at first.” 
Principles of motivational interviewing
• Express empathy through reflective listening
• Develop discrepancy between clients' goals or values and their current 
behavior
• Avoid argument and direct confrontation
• Adjust to client resistance rather than opposing it directly
• Support self-efficacy and optimism
Miller, W.R., and Rollnick, S. Motivational Interviewing: Preparing 
People To Change Addictive Behavior. New York: Guilford Press, 1991
Remaining patient-centered when there is a conflict 
(1) Understand the patient’s concerns and expectations 
(2) Validate concerns, emotions – use empathy, normalization
(3) Inform about reassuring features of the history and exam
(4) Explain your recommendation given risks and benefits 
(go back to (2) if needed)
(5) Flexibly negotiate alternatives 
(6) Explore for residual concerns
Fenton JJ et al. Promoting Patient-Centered Counseling to Reduce Use of Low-Value 
Diagnostic Tests: A Randomized Clinical Trial. JAMA Intern Med. 2016;176(2):191-197
(1) Understand the patient’s concerns and expectations
• Understand the patient’s concerns and expectations before addressing 
them.
• Ask open-ended questions
• Paraphrase what you hear
– the patient is more likely to feel understood 
– you are more likely to address what really matters to the patient
(2) Validate concerns and emotions
• Use empathy 
For example, “I can only imagine how frustrating it must be when the 
pain keeps you awake” 
• Use normalization 
For example, “many people feel even worse after their pain keeps them 
awake.”
(3) Inform about reassuring features of the history and exam
(4) Explain your recommendation given risks and benefits 
• For example, explain that opioids
– are unlikely to substantially reduce fibromyalgia pain more than 
temporarily
– risks of dependence and overdose outweigh these minimal benefits
• Allow the patient to respond 
• If she expresses additional concerns, or emotions, such as anger, go back to 
step (2): 
– Validate concerns, emotions, using empathy
(5) Flexibly negotiate alternatives 
• For example, trial of a tricyclic; and re-evaluation soon
(6) Explore for residual concerns
Six steps congruent with patient-centered care
(1) Understand the patient’s concerns and expectations 
(2) Validate concerns, emotions – use empathy, normalization
(3) Inform about reassuring features of the history and exam
(4) Explain your recommendation given risks and benefits 
(go back to (2) if needed)
(5) Flexibly negotiate alternatives 
(6) Explore for residual concerns
Fenton JJ et al. Promoting Patient-Centered Counseling to Reduce Use of Low-Value 
Diagnostic Tests: A Randomized Clinical Trial. JAMA Intern Med. 2016;176(2):191-197
How to increase effective communication when
• Communicating important information
– Pause and ask the patient what they heard 
– Correct misunderstandings, check for questions
• Motivating behavior change 
– Express empathy through reflective listening
– Develop discrepancy between patient goals and behavior
– Support self-efficacy and optimism
• Addressing conflicts 
– Understand and validate concerns and emotions 
– Explain your recommendation given benefits and risks
CDC Opioid Prescribing Guideline Mobile App
• CDC’s new Opioid Guide App makes it 
easier to apply the recommendations 




– Motivational Interviewing Practice
• Available today, download for free from 
your app store (iOS or Android)
• For more information, visit: 
www.cdc.gov/drugoverdose/prescribin
g/app.html
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EFFECTIVE COMMUNICATION WITH 
PATIENTS ABOUT OPIOID THERAPY
1. Provide communication strategies for talking 
with patients about benefits and harms of 
opioids when considering transition to long-
term use.
2. Provide communication strategies for talking 
with patients about tapering opioids.
3. Compare and contrast the communication 
challenges presented in the case studies with 




• SH:  Clerical job, 2 young children, ½ 
ppd cigarettes, “social drinker.”
• Family history: unremarkable
• +ROS:  Fatigue, poor sleep, 
headaches “from neck”, no weakness 
or numbness
EXAM: Fit. Neck limited ROM to flex, 
extend, rotate, and side-bend. Mild 
tenderness to palpate SCM, levator
scapulae, trapezius, paraspinal, and 
occipital muscles. Neurological: Normal
Prior non-drug treatments: PT x 2 “didn’t 
help” week 1-3
Imaging:  Normal c-spine X-rays from ED 
(day of injury)
CASE #1 
“Whiplash” 8 weeks after Car Crash: 37 y.o. woman 
Transition Into Long-Term Opioid Therapy
Pain Metrics (“PEG”)
• Pain Intensity: 9/10
• Pain Interference with 
Enjoyment of Life: 9/10
• Pain Interference with 
General Function: 9/10
PHQ-4: 8
ORT: 2 “low risk”
Pain related Rx:  
• Hydrocodone 10/325 6/d prn
• Methocarbamol 500 QID
• Cyclobenzaprine 10 mg prn
“Please, please refill my pain medications; 
if I didn’t have them I surely couldn’t manage 
my job and my family!” 
• Identify “Resistance Talk”
• Avoid arguing with her; elicit “Change Talk”
① “Tell me how they are helping you?”
② “What are your other concerns/fears/worries?”
③ “Have you had any side-effects?”
The Patient-Provider Dialogue (case 1)
“Well, you’re not just going to take away 
my pain pills, are you?”
• ‘Our shared goal is to help you take care of your family, and to 
keep you working.’
• ‘What are you concerned might happen if we reduced them 
very slowly?’
• ‘Would you mind if I told you what my concerns are?’
• ‘We are both looking at this together: the up-sides and the 
down-sides together.’
The Patient-Provider Dialogue (case 1, continued)
PSH:  L4-5 Discectomy/Laminectomy 
PMH:  HTN, Borderline DM, Hyperlipidemia, 
OSA
SH: Disabled stevedore x 6 years, married, 3 
children (8,12,14), 20 pack yr tobacco, denies 
alcohol
FH: DM, HTN, Lung cancer
+ROS: Fatigue, poor sleep, cough, 
constipation, poor libido 
ASE #2 
48 y.o. Man with CLBP 6 yrs after Spinal Fusion
Discontinuation of Long-term Opioid Therapy
Pain Metrics (“PEG” tool)
• Pain Intensity: 9/10
• Pain Interference with 
Enjoyment of Life: 
9/10








Opioids: Morphine ER 60 mg BID, Hydrocodone 10/325 x8/d 
Non-opioids: Carisoprodol 300 TID, Lorazepam 2 mg prn sleep
Physical Exam:  BP 154/94, BMI 32
• Limping and grimacing when moves
• Gait normal 
• Spine: Palpation tenderness axial and 
paravertebral lumbo-sacral back; ROM 
limited due to pain; SLRs LBP only; SIJ 
palpation and FABERE normal
• Neurologic: Cognition and affect 
normal; No motor atrophy or weakness 




48 y.o. Man with CLBP 6 yrs after Spinal Fusion
Discontinuation of Long-term Opioid Therapy (continued)
Imaging: 
• X-Ray (flex/ext) c/w 
described surgery, no 
migration of screws, no 
fracture, no abnormal 
motion
• Magnetic resonance 
image (MRI) 8 weeks 
ago: “…s/p L4-5 lam’y, disc 
space narrowing, moderate 
degenerative facet 
disease…”
• “…tapering opioids can be especially challenging after years 
on high dosages.”  Go slow if safety allows.
• Offer the opportunity to re-evaluate continued use of higher 
dose opioids in light of recent evidence regarding risks
• “empathically review benefits and risks of continued high-
dosage opioid therapy” and “offer to work with the patient to 
taper opioids to safer dosages”
• “very slow opioid tapers as well as pauses in the taper to 
allow gradual accommodation to lower opioid dosages.”
• Be aware that anxiety, depression, and opioid use disorder 
“might be unmasked by an opioid taper” 
“Established patients already taking high dosages of opioids, as 
well as patients transferring from other clinicians…”
Centers for Disease Control and Prevention MMWR March 15, 2016; 65:p23
“But doc, I can’t even manage on my current 
dose;  I really do need more, not less!”
• Identify “Resistance Talk”—pushing hard will 
lead to:
• “No way I can taper!”
• “My life is as bad as it can be”
• “What do you want me to do, lay in bed all day?”
The Patient-Provider Dialogue (case 2)
“But doc, I can’t even manage on my current dose;  
I really do need more, not less!”
• Avoid arguing with him; elicit “Change Talk”
① “Tell me how they are helping you?”
② “What are your other concerns/fears/worries?”
③ “Have you had any side-effects?
• Elicit: Symptoms of depression or addiction without 
using these words
• Elicit: Tolerance, withdrawal, control problems
The Patient-Provider Dialogue (case 2 continued)
1. Reflective listening is an opportunity 
for understanding your patient’s story.
2. Non-judgmental language supports 
collaborative treatment planning. 
3. Affirmative statements enable change 
by persuasion, not by argument.
4. An agreed upon opioid taper plan for 
your patient can result from shared 
medical decision-making.
Skillful Empathic Communication
To Ask a Question
 Using the Webinar System
 “Click” the Q&A tab at the top left of the webinar tool bar
 “Click”  in the white space
 “Type” your question
 “Click” ask
 On the Phone
 Press Star (*) 1 to enter the queue
 State your name
 Listen for the operator to call your name 
 State your organization and then ask your question
Thank you for joining!
Centers for Disease Control and Prevention 
Atlanta, Georgia
http://emergency.cdc.gov/coca 
Today’s webinar  will be archived
When:  A few days after the live call
What:  All call recordings (audio, webinar, and 
transcript)
Where:  On the COCA Call webpage 
http://emergency.cdc.gov/coca/calls/2016/callinfo_112916.asp
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Continuing Education  for COCA Calls
All continuing education (CME, CNE, CEU, CECH, ACPE, CPH, and 
AAVSB/RACE) for COCA Calls are issued online through the CDC Training 
& Continuing Education Online system (http://www.cdc.gov/TCEOnline/).
Those who participated in today’s COCA Call and who wish to receive 
continuing education  should complete the online evaluation by January 
22, 2017 with the course code WC2286. Those who will participate in the 
on demand activity and wish to receive continuing education should 
complete the online evaluation between January 23, 2017 and January 23, 
2019 will use course code WD2286. 
Continuing education certificates can be printed immediately upon 
completion of your online evaluation. A cumulative transcript of all 
CDC/ATSDR CE’s obtained through the CDC Training & Continuing 
Education Online System will be maintained for each user. 
Join the COCA 
Mailing List
Receive information about:
• Upcoming COCA Calls
• Health Alert Network notices
• CDC public health activations
• Emerging health threats
• Emergency preparedness and 
response conferences and 
training opportunities
http://emergency.cdc.gov/coca 
Join Us on 
Facebook
CDC Facebook page 
for clinicians! “Like” 
our page today to 
learn about upcoming 
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